10366466 · Active · incorporated 9 years, 10 months ago · Oxford
Biotech Biotech & Life Sciences Drug Discovery Series B+
Sitryx Therapeutics is a biotechnology company focused on developing novel immune therapies for autoimmune and inflammatory diseases.
See the complete cap table with every shareholder, founder tags, dilution across 25 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.